340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

MedPAC Report Addresses Key 340B Questions

 

March 18, 2020– A new report from a respected, independent congressional advisory panel sheds light on several of the key questions surrounding the 340B drug pricing program. In its March 2020 report to Congress, the Medicare Payment Advisory Commission (MedPAC) examined whether participation in the 340B program leads to higher drug spending for Medicare patients with five … [Read more...]

340B Is Serving the Underserved

 

April 10, 2019— For far too many patients in the U.S., access to needed health care is often out of reach. Millions of Americans – including those who live with disabilities, those with lower incomes, and members of racial and ethnic minority groups – struggle to get needed care. But hospitals participating in the 340B drug pricing program are helping counter that trend by … [Read more...]

Federal Court Blocks Medicare 340B Cuts

 

December 28, 2018— A federal court has found the Department of Health & Human Services (HHS) exceeded its authority by making deep cuts to Medicare Part B drug payments to many 340B hospitals. The decision marks a major victory for hospitals and their patients. Ruling on Dec. 27, the U.S. District Court for the District of Columbia issued a permanent injunction against … [Read more...]

Hits & Misses: 340B Commentary Gets Some Things Right But Misses on Others

 

November 28, 2018— In a recent commentary published in the Journal of the American Medical Association (JAMA), authors Peter Bach of Memorial Sloan Kettering Cancer Center and Rachel Sachs of Washington University in St. Louis call for an alternative financial mechanism for the 340B program, claiming the 340B program has resulted in market distortions and shifts in physician … [Read more...]

Busy times for 340B in Washington

 

November 19, 2018—The midterm elections were not the only source of Washington-related news in recent weeks with implications for the health care system. When it comes to 340B, several key events occurred in the days leading up to Election Day that might have longer-lasting implications for the program than the makeup of the 116th Congress. White House thinks globally on … [Read more...]

Congressional Leader Urges Medicare to Reverse 340B Hospital Cuts

 

October 19, 2018—Responding to a call for help from hospital CEOs in his home state and across the country, U.S. Senate Minority Leader Chuck Schumer (D-N.Y.) has urged Trump administration health officials to reverse a nearly 30 percent cut in Medicare Part B drug reimbursement to hospitals in the 340B drug pricing program. Speaking at United Memorial Medical Center (UMMC) … [Read more...]

Drug Prices Continue to Soar and the Public Notices

 

March 27, 2018—A trio of new reports out this past week indicates that the historic rise in prescription drug prices in the U.S. continues and the American public is concerned. First, a report by Axios found the prices of the top 20 drugs prescribed in the U.S. rose by more than 200 percent in the past 14 months. Based on an analysis by Pharmacy Benefits Consultants, Axios … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health